134 related articles for article (PubMed ID: 8799494)
1. Inhibition of P-glycoprotein-dependent multidrug resistance by an isoquinolinesulfonamide compound H-87 in rat ascites hepatoma AH66 cells.
Nakamura S; Minamino T; Nomura M; Wakusawa S; Miyamoto K; Hidaka H
Biol Pharm Bull; 1996 Jun; 19(6):886-9. PubMed ID: 8799494
[TBL] [Abstract][Full Text] [Related]
2. Increase of vinblastine accumulation by inhibitors of calmodulin-dependent cell functions in rat ascites hepatoma AH66 cells.
Wakusawa S; Takeda K; Miyamoto K; Hidaka H
Anticancer Res; 1992; 12(6B):2021-4. PubMed ID: 1363514
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance in Yoshida rat ascites hepatoma cell lines.
Miyamoto K; Wakusawa S; Nakamura S; Tajima K; Hidaka H
Anticancer Res; 1992; 12(3):649-53. PubMed ID: 1622121
[TBL] [Abstract][Full Text] [Related]
4. Characterization of naturally acquired multiple-drug resistance of Yoshida rat ascites hepatoma AH66 cell line.
Miyamoto K; Wakabayashi D; Minamino T; Nomura M; Wakusawa S; Nakamura S
Anticancer Res; 1996; 16(3A):1235-40. PubMed ID: 8702243
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity to antitumor drugs and vinblastine binding to membrane in rat ascites hepatoma AH66 cells.
Wakusawa S; Nakamura S; Inoko K; Miyamoto K
Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2182-4. PubMed ID: 1423778
[TBL] [Abstract][Full Text] [Related]
6. Overcoming of vinblastine resistance by isoquinolinesulfonamide compounds in adriamycin-resistant leukemia cells.
Wakusawa S; Nakamura S; Tajima K; Miyamoto K; Hagiwara M; Hidaka H
Mol Pharmacol; 1992 Jun; 41(6):1034-8. PubMed ID: 1614407
[TBL] [Abstract][Full Text] [Related]
7. Indoloquinoxaline compounds that selectively antagonize P-glycoprotein.
Smith CD; Myers CB; Zilfou JT; Smith SN; Lawrence DS
Oncol Res; 2000; 12(5):219-29. PubMed ID: 11417747
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
Mistry P; Stewart AJ; Dangerfield W; Okiji S; Liddle C; Bootle D; Plumb JA; Templeton D; Charlton P
Cancer Res; 2001 Jan; 61(2):749-58. PubMed ID: 11212278
[TBL] [Abstract][Full Text] [Related]
9. Reversal activity of cyclosporin A and its metabolites M1, M17 and M21 in multidrug-resistant cells.
Toffoli G; Corona G; Sorio R; Bertola A; Boiocchi M
Int J Cancer; 1997 May; 71(5):900-6. PubMed ID: 9180163
[TBL] [Abstract][Full Text] [Related]
10. Reversal of multidrug resistance by 7-O-benzoylpyripyropene A in multidrug-resistant tumor cells.
Rho MC; Hayashi M; Fukami A; Obata R; Sunazuka T; Tomoda H; Komiyama K; Omura S
J Antibiot (Tokyo); 2000 Oct; 53(10):1201-6. PubMed ID: 11132967
[TBL] [Abstract][Full Text] [Related]
11. Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugs.
Takara K; Tanigawara Y; Komada F; Nishiguchi K; Sakaeda T; Okumura K
Biol Pharm Bull; 1999 Dec; 22(12):1355-9. PubMed ID: 10746169
[TBL] [Abstract][Full Text] [Related]
12. BIBW22 BS, potent multidrug resistance-reversing agent, binds directly to P-glycoprotein and accumulates in drug-resistant cells.
Liu Z; Lheureux F; Pouliot JF; Heckel A; Bamberger U; Georges E
Mol Pharmacol; 1996 Sep; 50(3):482-92. PubMed ID: 8794885
[TBL] [Abstract][Full Text] [Related]
13. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
Friche E; Demant EJ; Sehested M; Nissen NI
Br J Cancer; 1993 Feb; 67(2):226-31. PubMed ID: 8094288
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of P-glycoprotein in heat- and/or drug-resistant hepatoma variants.
Pirity M; Hevér-Szabó A; Venetianer A
Cytotechnology; 1996; 19(3):207-14. PubMed ID: 8862008
[TBL] [Abstract][Full Text] [Related]
15. Reversal of vinblastine resistance in human leukemic cells by haloperidol and dihydrohaloperidol.
Kataoka Y; Ishikawa M; Miura M; Takeshita M; Fujita R; Furusawa S; Takayanagi M; Takayanagi Y; Sasaki K
Biol Pharm Bull; 2001 Jun; 24(6):612-7. PubMed ID: 11411546
[TBL] [Abstract][Full Text] [Related]
16. Effects of isoquinolinesulphonamide compounds on multidrug-resistant P388 cells.
Nakamura S; Wakusawa S; Tajima K; Miyamoto K; Hagiwara M; Hidaka H
J Pharm Pharmacol; 1993 Apr; 45(4):268-73. PubMed ID: 8098366
[TBL] [Abstract][Full Text] [Related]
17. Reversal of vinblastine resistance by a new staurosporine derivative, NA-382, in P388/ADR cells.
Miyamoto K; Wakusawa S; Inoko K; Takagi K; Koyama M
Cancer Lett; 1992 Jun; 64(2):177-83. PubMed ID: 1351792
[TBL] [Abstract][Full Text] [Related]
18. Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells.
Tamai I; Safa AR
J Biol Chem; 1991 Sep; 266(25):16796-800. PubMed ID: 1679434
[TBL] [Abstract][Full Text] [Related]
19. Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg(3).
Kim SW; Kwon HY; Chi DW; Shim JH; Park JD; Lee YH; Pyo S; Rhee DK
Biochem Pharmacol; 2003 Jan; 65(1):75-82. PubMed ID: 12473381
[TBL] [Abstract][Full Text] [Related]
20. Reversal of acquired resistance to doxorubicin in K562 human leukemia cells by astemizole.
Ishikawa M; Fujita R; Takayanagi M; Takayanagi Y; Sasaki K
Biol Pharm Bull; 2000 Jan; 23(1):112-5. PubMed ID: 10706423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]